Response Biomedical Enlists Shanghai Elite as China Distributor

Response Biomedical of Vancouver has granted Shanghai Elite Biotech an exclusive license to distribute its RAMP ® cardiovascular point-of-care test in all of mainland China. For more than a year, Elite has been distributing the portfolio in an unspecified number of eastern and southern China provinces. Response Bio was pleased with the uptick in sales in the areas and has expanded the agreement. More details.... Stock Symbol: (TO: RBM) Share this with colleagues: // //